Literature DB >> 19195516

Internal medicine physicians' perceptions regarding rate versus rhythm control for atrial fibrillation.

James M McCabe1, Colleen J Johnson, Gregory M Marcus.   

Abstract

Atrial fibrillation (AF) is often managed by general internal medicine physicians. Available data suggest that guidelines regarding AF management are often not followed, but the reasons for this remain unknown. The aim of this study was to assess the knowledge and beliefs of internists regarding strategies to treat AF. A national electronic survey of internal medicine physicians regarding their perceptions of optimal AF management, with an emphasis on the rationale for choosing a rhythm- or rate-control strategy, was conducted. One hundred forty-eight physicians from 36 different states responded (representing > or =19% of unique e-mails opened). Half the respondents reported managing their patients with AF independently without referral to cardiologists. Seventy-three percent of participants believed that a rhythm-control strategy conveys a decreased stroke risk, 64% believed that there is a mortality benefit to rhythm control, and 55% thought that it would help avoid long-term anticoagulation. Comparing those who preferred a rhythm-control strategy to everyone else, those who favored rhythm control statistically significantly more often believed that rhythm control reduces the risk for stroke (96% vs 67%, p = 0.009) and that rhythm control allows the discontinuation of anticoagulation therapy (76% vs 49%, p = 0.045). In conclusion, contrary to available data in clinical trials and recent guidelines regarding the rationale for choosing a rhythm-control strategy in treating patients with AF, most study participants believed that rhythm control decreases stroke risk, decreases mortality, and allows the discontinuation of anticoagulation therapy. These prevalent misconceptions may substantially contribute to guideline nonadherence.

Entities:  

Mesh:

Year:  2008        PMID: 19195516      PMCID: PMC3161619          DOI: 10.1016/j.amjcard.2008.10.017

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Authors:  P Dorian; W Jung; D Newman; M Paquette; K Wood; G M Ayers; J Camm; M Akhtar; B Luderitz
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

2.  Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Anne B Curtis; Bernard J Gersh; Scott D Corley; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Joyce C Kellen; Mary Mickel; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse
Journal:  Am Heart J       Date:  2005-04       Impact factor: 4.749

Review 3.  A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need.

Authors:  Albert L Waldo
Journal:  Am Heart J       Date:  2006-04       Impact factor: 4.749

4.  Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.

Authors:  Mina K Chung; Lynn Shemanski; David G Sherman; H Leon Greene; David B Hogan; Joyce C Kellen; Soo G Kim; Lisa Warsinger Martin; Yves Rosenberg; D George Wyse
Journal:  J Am Coll Cardiol       Date:  2005-10-21       Impact factor: 24.094

5.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

6.  Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.

Authors:  A A Pradhan; M A H Levine
Journal:  Can J Clin Pharmacol       Date:  2002

7.  Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

Authors:  David G Sherman; Soo G Kim; Bradley S Boop; Scott D Corley; John P Dimarco; Robert G Hart; L Julian Haywood; Keith Hoyte; Elizabeth S Kaufman; Michael H Kim; Elaine Nasco; Albert L Waldo
Journal:  Arch Intern Med       Date:  2005-05-23

8.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

Authors:  Jörg Carlsson; Sinisa Miketic; Jürgen Windeler; Alessandro Cuneo; Sebastian Haun; Stefan Micus; Sabine Walter; Ulrich Tebbe
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

9.  Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.

Authors:  Grzegorz Opolski; Adam Torbicki; Dariusz A Kosior; Marcin Szulc; Beata Wozakowska-Kaplon; Piotr Kolodziej; Piotr Achremczyk
Journal:  Chest       Date:  2004-08       Impact factor: 9.410

10.  Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).

Authors:  Ronald S Freudenberger; Alan C Wilson; John B Kostis
Journal:  Am J Cardiol       Date:  2007-06-04       Impact factor: 2.778

View more
  2 in total

1.  Outcomes in patients with dual antegrade conduction in the atrioventricular node: insights from a multicentre observational study.

Authors:  Jens Hartmann; Christiane Jungen; Sebastian Stec; Niklas Klatt; Stephan Willems; Hisaki Makimoto; Daniel Steven; Helmut Pürerfellner; Martin Martinek; Christian Meyer
Journal:  Clin Res Cardiol       Date:  2020-01-30       Impact factor: 5.460

2.  Assessment of the adherence of cardiologists to guidelines for the treatment of atrial fibrillation.

Authors:  Cézar R van der Sand; Tiago Luiz Luz Leiria; Renato Abdala Karam Kalil
Journal:  Arq Bras Cardiol       Date:  2013-07-23       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.